Company Overview of Episome Biotechnologies
Episome Biotechnologies operates as a biotechnology company that focuses on industrial enzyme technologies. The company offers EpiCellulyse XT, an enzymatic solution that facilitates the production of biogas from paper mill sludge; and used to convert paper industry waste into raw material for use in biogas plants. It serves biogas, textile, leather, paper, starch, detergent, rubber, and biofuel industries. The company was founded in 2014 and is headquartered in Gebze, Turkey.
Gebze Organize Sanayi Bölgesi
2.Üretim Birimi 6.Ünite 2.Kisim
Founded in 2014
90 262 678 72 56
Key Executives for Episome Biotechnologies
Episome Biotechnologies does not have any Key Executives recorded.
Similar Private Companies By Industry
|Genz Biyoteknoloji AS||Europe|
|GlakoLens BIYOMEDIKAL BIYOTEKNOLOJI SANAYI VE TICARET ANONIM SIRKETI||Europe|
|Ars Arthro Biyoteknoloji A.S.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Episome Biotechnologies, please visit www.episomebiotech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.